No abstract

Objetivo: analisar os indicadores epidemiológicos de crianças e adolescentes acometidos pela Covid-19 na região Nordeste do Brasil. Método: estudo ecológico com casos de Covid-19, nos estados do Nordeste. Calculou-se taxas de letalidade, prevalência, índice acumulado diário e razão de leitos de UTI. Analisou-se dados consolidados até 21 de agosto de 2020. Resultados: houve 74.705 casos de Covid-19, com prevalência do sexo feminino e quanto a faixa etária àqueles entre 10 a 19 anos. Letalidade foi de 8%, prevalência de 321/100.000 habitantes e razão de leitos menor que dois. Houve significância para relação entre o maior número de óbitos e o menor número de leitos de UTI (p=0.001), maior prevalência de casos em razão da menor quantidade de leitos de UTI (p=0.007). Conclusão: os indicadores revelam insuficiência quanto aos leitos para a doença, alta letalidade e prevalência, bem como quantidade razoável dos leitos de UTI.

Objective: to map the scientific production on patients infected by COVID-19 and the occurrence of stroke. Method: a scoping review, according to the framework proposed by the Joanna Briggs Institute, using the LILACS, MEDLINE, WoS, EMBASE, CINAHL and SCOPUS databases, from April to September 2020. The following keywords were used: coronavirus infections, stroke, nervous system diseases and inpatients, based on the Medical Subject Headings. Results: 24 studies that evidenced specific clinical symptoms of stroke such as dysarthria, facial paralysis, sensory deficit, headache, hemiparesis and ataxia in patients with COVID-19 were included. The association between stroke and COVID-19 was found by the following exams: C-reactive protein, D-dimer, computed tomography and, magnetic resonance, among others, as well as by care procedures focused on the findings in the exams, associated with three clinical outcomes, based on the brain ischemia zone affected and the time of viral manifestation of each patient. Conclusion: the specific clinical manifestations of patients who suffered a stroke after COVID-19 were mapped, as well as diagnostic procedures and therapies used, in addition to identifying neurological damage based on the clinical outcome of these patients.

No abstract

No abstract